Effects of nicotinamide and carbogen on oxygenation in human tumor xenografts measured with luminescense based fiber-optic probes

Radiotherapy and Oncology

Volumn 57, Issue 1, 2000, Pages 21-30

  Bussink, Johan ^a   Kaanders, Johannes H A M ^a   Strik, Ankie M ^a   van der Kogel, Albert J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Carbogen; Hypoxia; Nicotinamide; OxyLite; Pimonidazole; Time resolved luminescensce

Indexed keywords

CARBOGEN; ENFLURANE; NICOTINAMIDE; PIMONIDAZOLE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEVICE; FIBER OPTICS; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HYPOXIC CELL; IMAGE PROCESSING; LUMINESCENCE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TECHNIQUE; TISSUE OXYGENATION; TUMOR CELL LINE; TUMOR XENOGRAFT;

ANALYSIS OF VARIANCE; ANIMAL; CARBON DIOXIDE; CELL HYPOXIA; COMPARATIVE STUDY; DISEASE MODELS, ANIMAL; FIBER OPTICS; HUMAN; LINEAR MODELS; LUMINESCENCE; NIACINAMIDE; NITROIMIDAZOLES; OXYGEN; RADIATION-SENSITIZING AGENTS; SENSITIVITY AND SPECIFICITY; SUPPORT, NON-U.S. GOV'T; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0034307206     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(00)00275-9     Document Type: Article

References (54)

1. Evidence that hypoxia markers detect oxygen gradients in liver: pimonidazole and retrograde perfusion in rat livers
2. Longevity of pimonidazole adducts in spontaneous canine tumors as an estimate of hypoxic cell lifetime
3. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck
4. SR 4233 (tirapazamine): a new anticancer drug exploiting hypoxia in solid tumors
5. Multi-parameter analysis of vasculature, perfusion and proliferation in human tumor xenografts
6. Vascular architecture and microenvironmental parameters in human squamous cell carcinoma xenografts: effects of carbogen and nicotinamide
7. Clinical results and tumor microenvironmental effects of accelerated radiotherapy with carbogen and nicotinamide
8. Optical sensor based oxygen tension measurements correspond with hypoxic marker binding in three human tumor xenograft lines
9. Measurement of tumor oxygenation: a comparison between polarographic needle electrodes and a time-resolved luminescence-based optical sensor
10. New insights into factors influencing the clinically relevant oxygen enhancement ratio
11. Inducible repair and the two forms of tumor hypoxia: time for a paradigm shift
12. Identification of non-proliferating but viable hypoxic tumor cells in vivo
13. Detection of hypoxia in human squamous cell carcinoma by EF5 binding
14. 2 histography
15. Effects of carbogen plus fractionated irradiation on KHT tumor oxygenation
16. Enhancement of tumor perfusion and oxygenation by carbogen and nicotinamide during single- and multifraction irradiation
17. Pharmacological modifications of the partial pressure of oxygen in murine tumors: evaluation using in vivo EPR oximetry
18. Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy
19. Changes of oxygen tension in experimental tumors after a single dose of X-ray irradiation
20. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy
21. Late results of a trial of hyperbaric oxygen and radiotherapy in head and neck cancer: a rationale for hypoxic cell sensitizers?
22. 2 predicts survival in advanced cancer of the uterine cervix
23. Tumor hypoxia in pelvic recurrences of cervical cancer
24. Tumor radiosensitization by nicotinamide: a result of improved blood perfusion and oxygenation
25. Overcoming tumor radiation resistance resulting from acute hypoxia
26. Reducing acute and chronic hypoxia in tumors by combining nicotinamide with carbogen breathing
27. A dual hypoxic marker technique for measuring oxygenation change within individual tumors
28. Radiotherapy with carbogen breathing and nicotinamide in head and neck cancer: feasibility and toxicity
29. Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for laryngeal cancer
30. Accelerated radiotherapy with carbogen and nicotinamide (ARCON): from mouse to man
31. Proliferation and hypoxia in human squamous cell carcinoma of the cervix: first report of combined immunohistochemical assays
32. A therapeutic benefit from combining normobaric carbogen or oxygen with nicotinamide in fractionated X-ray treatments
33. Oxygen dependence of cellular uptake of EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acet amide]: analysis of drug adducts by fluorescent antibodies vs bound radioactivity
34. Regional tumor oxygen dynamics: 19F PBSR EPI of hexafluorobenzene
35. Changes in tumor hypoxia measured with a double hypoxic marker technique
36. An efficient procedure for the 1-alkylation of 2-nitroimidazoles and the synthesis of a probe for hypoxia in solid tumors
37. Changes in the oxygenation of head and neck tumors during carbogen breathing
38. Regional tumor oxygenation and measurement of dynamic changes
39. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck
40. Radiation-induced reoxygenation in the SCC VII murine tumor: evidence for a decrease in oxygen consumption and an increase in tumor perfusion
41. A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) protocol 5-85
42. Fluorescence immunohistochemical detection of hypoxic cells in spheroids and tumors
43. Comparisons among pimonidazole binding, oxygen electrode measurements and radiation response in C3H mouse tumors
44. Application of an image analysis system to the quantitation of tumor perfusion and vascularity in human glioma xenografts
45. Carbogen and nicotinamide as radiosensitizers in a murine mammary carcinoma using conventional and accelerated radiotherapy
46. Effect of carbogen breathing on the physiological profile of human glioma xenografts
47. 2 tension measurements
48. Hyperbaric oxygen and radiotherapy: a medical research council trial in carcinoma of the cervix
49. Simultaneous triple staining for hypoxia, proliferation, and DNA content in murine tumors
50. Vascular density in melanoma xenografts correlates with vascular permeability factor expression but not with metastatic potential
51. Vascular architecture and hypoxic profiles in human head and neck squamous cell carcinomas
52. Cells at intermediate oxygen levels can be more important than the 'hypoxic fraction' in determining tumor response to fractionated radiotherapy
53. Measurement of oxygen tension in tumors by time-resolved fluorescence